Common Rule

45 C.F.R. Part 46

Federal Policy for the Protection of Human Subjects

In force since July 19, 2018

Who it applies to

  • Human-subjects research conducted or supported by a Common Rule department or agency
  • Research at institutions that have voluntarily extended the policy to all their research through a federalwide assurance

Consumer rights

  • Access / know, grantedObtain the personal data held about you, and the categories, sources and purposes behind it.
  • Correction, not granted
  • Deletion / erasure, not granted
  • Portability, not granted
  • Opt out of sale / sharing, not granted
  • Opt out of targeted advertising, not granted
  • Opt out of profiling, not granted
  • Limit sensitive data use, not granted
  • Human review of automated decisions, not granted
  • Non-discrimination, not granted
  • Appeal a refusal, grantedHave a denied request reconsidered through a stated appeals process.
  • Private right of action, not granted

Obligations

Consent model
Opt-in
Universal opt-out signal
Not required
Risk assessments
Required for higher-risk processing
Data protection officer
Not required
Records of processing
Not required
Processor contract
Not required
Right to cure
None: enforcement may follow immediately
Data broker registration
Not required
Minors
Parental permission plus the child's assent, with the IRB judging the child's capacity to assent.

Breach notification

To individuals
No breach-notification duty of its own
To the regulator
Unanticipated problems involving risks to subjects are reported to OHRP and the IRB promptly
What triggers it
Not applicable as a breach regime; the reportable event is an unanticipated problem or a serious non-compliance finding

Penalties

Headline
Suspension or termination of federal funding and of the institution's assurance, rather than a monetary penalty
Private right of action
No, enforcement is by the regulator only
Notes
TWO SEPARATE PERMISSIONS, AND RESEARCHERS ROUTINELY SECURE ONE. IRB approval under this Part authorises the research; it does not authorise a covered entity to hand over the records. That takes a HIPAA authorization or a waiver under 45 C.F.R. § 164.512(i). Clearing the IRB and assuming the data may now flow is the failure mode the pathway instrument's research lane is built around.

Exemptions

Entities

  • Privately funded research at an institution that has not extended the policy, which is reached by the FDA's rules or by nothing at all

Data

  • Secondary research on information collected for another purpose, where the identifiers are not accessible to the investigator
  • Eight categories of exempt research, including certain benign behavioural interventions and public-benefit programme evaluation

Amendment history

  1. January 21, 2019

    Revised Common Rule, general compliance date

    Required a concise key-information section at the front of consent forms, allowed broad consent for secondary research use of identifiable data, and mandated single IRB review for cooperative research.

Sources

Timeline

todayCommon Rule in forceJuly 19, 2018Revised Common Rule, general compliance dateJanuary 21, 2019